Thursday, March 09, 2017
TIME: 6:30 PM - 8:00 PM
LOCATION: Martin Trust Center, E40-160register here
Alex de Winter is the director of Healthcare for GE Ventures, and will be discussing what GE’s move to Boston means for the MIT entrepreneurship ecosystem.
Alex de Winter is a managing director at GE Ventures. He invests in precision medicine startups, leading investments in Labcyte, RainDance Technologies, Syapse, and Veracyte. Alex joined GE from Mohr Davidow Ventures, where he served as a board observer for CardioDx, Corventis, Crescendo Bioscience, DVS Sciences, and Personalis. He started his career as a research scientist with 454 Life Sciences and Pacific Biosciences.
Alex has an MBA from UC Berkeley, a Ph.D. in chemistry from Stanford, and graduated from Amherst College.